Rijksinstituut voor Volksgezondheid en Milieu
he RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patie | RIVM
Bron:
rivm.nl